U.S. Telecom Services and Carriers Stock News

SolarEdge Technologies (SEDG) shares have been in focus after rebounding from losses linked to a customer insolvency, with sentiment also supported by stronger interest in clean energy and a new research and development center in India. See our latest analysis for SolarEdge Technologies. Despite the recent 1-day share price decline of 9.62% and a 7-day share price return down 26.38%, SolarEdge’s 30-day and year to date share price returns of 39.95% and 84.31%, together with a 1-year total...

BankUnited (BKU) is back on investors’ radar after recent share price moves, with the stock last closing at $47.67. That has renewed focus on its profitability, balance sheet strength, and valuation. See our latest analysis for BankUnited. Recent trading has been relatively steady, with a 1 day share price return of 1.12% and a 90 day share price return of 8.54%. The 1 year total shareholder return of 38.57% and 3 year total shareholder return of 131.16% point to stronger momentum over a...

In March 2026, Red Rock Resorts’ Station Casinos subsidiary suffered a cybersecurity data breach that was disclosed in May and has since prompted a class action lawsuit alleging negligence and delayed notification to affected individuals. The company’s decision not to file an SEC Form 8-K about the incident, unlike several Nevada casino peers, raises questions about its disclosure practices and governance oversight around cyber risk. We’ll now examine how the class action and questions over...

Black Hills (BKH) is drawing fresh attention after recent trading left the stock down about 6% over the past week and roughly 10% over the past month, which has sharpened the focus on its utility-driven fundamentals. See our latest analysis for Black Hills. At a share price of $67.78, Black Hills has seen its recent share price momentum fade, with the stock down 5.9% over the past week and 9.9% over the past month, even as its 1 year total shareholder return sits at 22.3%. If this shift in...

Recent stock performance snapshot Plug Power (PLUG) has seen sharp price swings recently, with the stock down 8.8% in the past day and 28.9% over the past week, while the past 3 months show a 30.5% gain. Over longer periods, the stock is up 127.3% over the past year but has fallen 73.3% over 3 years and 90.0% over 5 years, highlighting how timing has heavily influenced investor experience. See our latest analysis for Plug Power. At a share price of US$2.91, Plug Power’s recent pullback,...

Rackspace Technology (RXT) stock is in focus after the company announced a new regional headquarters in Riyadh, Saudi Arabia, aiming to support cloud and AI projects tied to Vision 2030. See our latest analysis for Rackspace Technology. That Riyadh announcement lands after a volatile stretch, with the latest share price at $4.66, a 90 day share price return of 143% and a 1 year total shareholder return of 253%, although short term 7 and 30 day share price returns have recently pulled back. If...

H.B. Fuller stock snapshot after recent performance H.B. Fuller (FUL) has attracted attention after a 3.3% gain in the latest session, alongside a modest move over the past month and a higher total return over the past year and past 3 months. See our latest analysis for H.B. Fuller. At a share price of US$62.03, H.B. Fuller has paired a 3.33% 1 day share price gain with an 8.18% 90 day share price return. The 1 year total shareholder return of 7.48% contrasts with declines over the 3 and 5...

In recent days, ProFrac Holding was swept up in sharp swings across energy stocks as direct military actions between Israel and Iran, and subsequent US comments on a possible response over the Strait of Hormuz, heightened and then partially eased geopolitical risk concerns for the oil and gas sector. This turmoil underscored how ProFrac’s fortunes can be influenced less by its own operations and more by shifting expectations around global supply security and demand for energy services amid...

In early June 2026, CareDx reported Q1 revenue growth of 39% year over year, raised full-year guidance to US$447–US$465 million with adjusted EBITDA of US$43–US$57 million, advanced its AI-enabled transplant diagnostics, and agreed to acquire Naveris while its CEO Hanna John Walter JR sold 4,835 shares as part of ongoing insider sales. The Naveris deal shifts CareDx further into oncology minimal residual disease testing with Medicare-covered NavDx and a planned AlloHeme launch for AML and...

Recent commentary around Iron Mountain (IRM) has focused on its mix of REIT stability and exposure to digital infrastructure, following notable 2025 revenue contributions from data center and asset lifecycle management segments that have attracted investor attention. See our latest analysis for Iron Mountain. At a share price of US$126.14, Iron Mountain has had a 1 day share price return of 2.14% and a 90 day share price return of 17.24%. Its 1 year total shareholder return of 29.19% and 5...

In recent weeks, GE HealthCare received FDA 510(k) clearance for its MIM Contour ProtégéAI+ 2.0 auto-contouring software and showcased a broad suite of AI-enabled imaging and nuclear medicine tools, while also opening a new Imaging Research & Development Center in Ohio with leading academic partners. Together, these developments underscore GE HealthCare’s push to embed AI and advanced imaging across oncology, cardiology and neurology workflows while deepening industry–academia collaboration...

In recent weeks, Arcus Biosciences announced a clinical trial collaboration with Bristol Myers Squibb to add its HIF-2a inhibitor casdatifan to the BMS-sponsored ROSETTA RCC-208 trial in advanced renal cell carcinoma, while regulators accepted a Priority Review for Camzyos in adolescent obstructive hypertrophic cardiomyopathy and approved Opdivo plus AVD for newly diagnosed advanced classical Hodgkin lymphoma in the EU. Together with positive Phase 3 data for the multiple myeloma candidate...

Zai Lab Limited recently announced that China’s National Medical Products Administration approved the Biologics License Application for TIVDAK (tisotumab vedotin) to treat adult patients with recurrent or metastatic cervical cancer whose disease progressed on or after chemotherapy, based on the Phase 3 innovaTV 301 trial showing an overall survival benefit and no new safety signals in the China subpopulation. This approval gives Zai Lab exclusive rights to commercialize TIVDAK across Greater...

Alnylam Pharmaceuticals (ALNY) has come back into focus after the company outlined 2030 financial goals and reiterated AMVUTTRA’s central role, even as fresh headlines highlighted its AI partnership with Inceptive Nucleics. See our latest analysis for Alnylam Pharmaceuticals. Despite the recent AI collaboration and refreshed 2030 goals, Alnylam’s share price has been under pressure year to date, with a year to date share price return of down 25.6%. However, the 3 year total shareholder return...

Knife River (KNF) moved higher alongside a broad rally in building materials stocks, as investors reacted to more upbeat sentiment around infrastructure spending, housing activity, and construction forecasts across the industry. See our latest analysis for Knife River. That move comes after a mixed stretch, with the stock’s 1 day share price return of 5.72% standing against a 30 day share price return down 15.64% and a 1 year total shareholder return down 14.45%, while the 3 year total...

Emerson Electric (EMR) is back in focus after announcing a collaboration with SiMa.ai to bring machine learning System on Chip technology into its industrial PCs, putting fresh attention on the stock’s Industrial AI ambitions. See our latest analysis for Emerson Electric. Emerson Electric’s recent Industrial AI partnership with SiMa.ai comes after a steady year of gains, with the share price up 4.86% year to date and a 1-year total shareholder return of 14.02%. The 3-year total shareholder...

In early June 2026, Ulta Beauty reported first-quarter sales of US$3,163.86 million and net income of US$340.47 million, raised its full-year diluted EPS outlook, completed a sizeable share repurchase tranche, entered a new Klarna payments partnership, expanded marketing through a Supergirl collaboration, and secured shareholder approval for officer exculpation and exclusive legal forum amendments. The combination of stronger-than-expected earnings, enhanced digital and experiential...

In early June 2026, Beam Therapeutics reported positive clinical trial data for its gene-editing candidate BEAM-302, showing sustained protective protein levels that support a potential accelerated review pathway by the FDA for treating alpha-1 antitrypsin deficiency. This progress in BEAM-302 strengthens Beam’s broader precision genetic medicine pipeline, underscoring how individual program milestones can influence perceptions of its overall technology platform and future treatment...

In early June 2026, Modine Manufacturing announced a long-term AI data center cooling agreement expected to generate over US$4.00 billion in sales between 2027 and 2029, including a US$165 million upfront payment to expand manufacturing capacity. Coming just after Modine raised its growth outlook and moved to become a pure-play climate solutions provider, the deal highlights how hyperscale data center demand is reshaping the company’s business mix toward higher-value cooling solutions. Next,...

AXIA Energia stock snapshot AXIA Energia (AXIA) has drawn attention after recent trading performance, with the stock at $9.83 and mixed short term returns, including a gain of 1.03% over the past day but pressure over the past month. See our latest analysis for AXIA Energia. Recent trading has been choppy, with the share price down 18.02% over the past 30 days and 16.55% over 90 days, yet the 1 year total shareholder return of 76.22% shows how strongly long term holders have been rewarded. If...

Driven Brands Holdings (DRVN) has drawn investor attention after recent share price moves, with the stock down 1.9% on the day and mixed returns over the week, month, and past 3 months. See our latest analysis for Driven Brands Holdings. At a share price of $13.21, recent weakness, including a 1 day share price return decline of 1.93%, comes after a stronger 90 day share price return of 25.33%. However, the 1 year total shareholder return is down 25.87%, pointing to fading longer term...

Spyre Therapeutics recently completed enrollment for the psoriatic arthritis and axial spondyloarthritis sub-studies in its SKYWAY Phase 2 trial of SPY072, while reiterating timelines for multiple rheumatic disease readouts and showcasing supportive preclinical anti-TL1A data at the 2026 European Congress of Rheumatology. Together with an expanded licensing field for SPY003 beyond inflammatory bowel disease, these developments highlight Spyre’s push to build a broader immunology franchise...

Recently, Zacks Investment Research upgraded Stock Yards Bancorp (SYBT) to a Rank #2 (Buy), citing an improved earnings outlook and upward-trending estimates. This shift in analyst view, combined with neutral short-term quantitative signals, highlights a changing perception of the bank’s earnings resilience. We’ll now examine how this Zacks Rank upgrade, tied to improved earnings expectations, reshapes Stock Yards Bancorp’s broader investment narrative. Outshine the giants: these 14...

What the Tuscaloosa resort announcement means for Travel + Leisure (TNL) Travel + Leisure (TNL) is extending its Sports Illustrated Resorts brand with a ground-up, mixed-use project in Tuscaloosa, Alabama, near the University of Alabama, tying year-round hospitality and residential offerings to a large college sports market. See our latest analysis for Travel + Leisure. Recent momentum has been building, with a 1-month share price return of 9.71% and a 1-year total shareholder return of...